8 Appraisal Committee members, guideline representatives and NICE project team
Appraisal Committee members
The Appraisal Committees are standing advisory committees of NICE. Members are appointed for a 3‑year term. A list of the Committee members who took part in the discussions for this appraisal appears below. There are 4 Appraisal Committees, each with a chair and vice chair. Each Appraisal Committee meets once a month, except in December when there are no meetings. Each Committee considers its own list of technologies, and ongoing topics are not moved between Committees.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.
The minutes of each Appraisal Committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Professor Gary McVeigh (Chair)
Professor of Cardiovascular Medicine, Queen's University Belfast and Consultant Physician, Belfast City Hospital
Dr Lindsay Smith (Vice Chair)
GP, West Coker Surgery, Somerset
Dr Graham Ash
Consultant in General Adult Psychiatry, Lancashire Care NHS Foundation Trust
Dr Aomesh Bhatt
Regulatory and Medical Affairs Director Europe and North America, Reckitt Benckiser
Dr Andrew Black
GP, Mortimer Medical Practice, Herefordshire
Professor David Bowen
Consultant Haematologist, Leeds Teaching Hospitals NHS Trust
Dr Matthew Bradley
Therapy Area Leader, Global Health Outcomes, GlaxoSmithKline
Dr Ian Campbell
Honorary Consultant Physician, Llandough Hospital, Cardiff
Tracey Cole
Lay Member
Dr Ian Davidson
Lecturer in Rehabilitation, University of Manchester
Professor Simon Dixon
Professor of Health Economics, University of Sheffield
Dr Martin Duerden
Assistant Medical Director, Betsi Cadwaladr Health Board, North Wales
Susan Dutton
Senior Medical Statistician, Oxford Clinical Trials Research Unit
Dr Alexander Dyker
Consultant Physician, Wolfson Unit of Clinical Pharmacology, University of Newcastle
Christopher Earl
Surgical Care Practitioner, Wessex Neurological Centre at Southampton University Hospital
Gillian Ells
Prescribing Adviser – Commissioning, NHS Hastings and Rother and NHS East Sussex Downs and Weald
Professor Paula Ghaneh
Professor and Honorary Consultant Surgeon, University of Liverpool
Dr Susan Griffin
Research Fellow, Centre for Health Economics, University of York
Professor Carol Haigh
Professor in Nursing, Manchester Metropolitan University
Professor John Henderson
Professor of Paediatric Respiratory Medicine, University of Bristol and Bristol Royal Hospital for Children
Dr Paul Hepple
General Practitioner, Muirhouse Medical Group
Professor John Hutton
Professor of Health Economics, University of York
Professor Peter Jones
Emeritus Professor of Statistics, Keele University
Professor Steven Julious
Professor in Medical Statistics, University of Sheffield
Dr Tim Kinnaird
Lead Interventional Cardiologist, University Hospital of Wales, Cardiff
Emily Lam
Lay Member
Dr Warren Linley
Senior Medicines Commissioning Pharmacist, Staffordshire and Lancashire Commissioning Support Unit
Malcolm Oswald
Lay Member
Dr Oluwafemi Oyebode
Professor of Psychiatry and Consultant Psychiatrist, The National Centre for Mental Health
Dr John Radford
Director of Public Health, Rotherham Primary Care Trust and Metropolitan Borough Council
Dr Peter Selby
Consultant Physician, Central Manchester University Hospitals NHS Foundation Trust
Dr Mohit Sharma
Consultant in Public Health, Public Health England
Dr Peter Sims
GP, Devon
Dr Murray Smith
Associate Professor in Social Research in Medicines and Health, University of Nottingham
Cliff Snelling
Lay Member
NICE project team
Each technology appraisal is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the appraisal), a technical adviser and a project manager.
Ian Watson
Technical Lead
Eleanor Donegan
Technical Adviser
Kate Moore
Project Manager
Changes after publication
March 2017: under the original patient access scheme the company provided 2x45‑mg pre-filled syringes, for patients who needed the higher dose of 90‑mg, at the same total cost to the NHS as for a single 45‑mg pre-filled syringe. The patient access scheme has been withdrawn because the company now provides a 90‑mg vial at the same cost as the 45‑mg vial.